MEIS1 and ovarian serous cystadenocarcinoma: In addition, MEIS1 was diversely expressed in multiple molecular subtypes of ACC, BRCA, esophageal carcinoma (ESCA), GBM, HNSC, KIRP, LGG, LIHC, LUSC, ovarian serous cystadenocarcinoma (OV), PCPG, PRAD, STAD and UCEC (all p < 0.05) (Figure 5b).